AT&T makes two significant strategic moves, acquiring Lumen's fiber assets to expand its broadband footprint and partnering to launch a network-based fall detection device for seniors, as it seeks to leverage its core infrastructure for future growth.
Realty Income (O) has formed a major partnership with Singapore's sovereign wealth fund GIC, committing over $1.5 billion to build-to-suit logistics properties, while simultaneously making its first investment in Mexico. This strategic move diversifies the REIT's portfolio into high-growth logistics and international markets, leveraging external capital to fuel expansion.
Shares of USA Rare Earth (USAR) have skyrocketed over 56% in the past month, defying its reported zero revenue and substantial losses. As the critical minerals sector heats up, investors are left to question whether this is speculative frenzy or a bet on a strategic national resource.
Helmerich & Payne (HP) is navigating a pivotal moment with a planned CEO succession and the reactivation of seven idle rigs in Saudi Arabia, sparking renewed interest in the drilling contractor's valuation and strategic direction amid a volatile energy market.
Following its August 2025 rebrand from U.S. Cellular, Array Digital Infrastructure (AD) is navigating mixed investor sentiment. While short-term share price weakness contrasts with strong multi-year returns, analysts debate whether the company's focus on wireless infrastructure presents a buying opportunity or signals challenges ahead.
Despite a recent dip in its share price, Kinergy Advancement Berhad (KLSE:KINERGY) presents a complex picture with solid financial fundamentals and robust earnings growth. This analysis delves into whether the market has overlooked its potential.
The U.S. Food and Drug Administration has removed a clinical hold on Intellia Therapeutics' pivotal Phase 3 study of its gene-editing candidate for a rare, progressive disease, allowing the trial to proceed with enhanced safety monitoring. The move refocuses investor attention on the company's pipeline and long-term valuation prospects.
Amid broader market pressures, a closer look at the UK's small-cap segment reveals potential opportunities. We examine three companies—CyanConnode, TPXimpact, and Gulf Keystone Petroleum—navigating challenges while showing flashes of promise for risk-tolerant investors.
Stoneridge, Inc. has completed the sale of its Control Devices segment to private equity firm Center Rock Capital Partners for $59 million. The move is part of a strategic pivot to strengthen its balance sheet and concentrate resources on advanced vision, safety, and connectivity technologies for commercial vehicles.
Amid global economic crosscurrents, UK investors are turning their focus to growth companies with significant insider ownership, a signal often interpreted as strong alignment between leadership and shareholder interests. We examine three such firms standing out in the current market.
Analyst Dan Ives of Wedbush reiterates an Outperform rating on Amazon, citing robust cloud growth and a positive setup for the upcoming quarterly report. The firm forecasts strong operating income and sees 2026 as a potential inflection year for AWS.
Arcellx (ACLX) shares are caught in a tug-of-war between conflicting valuation signals. While a sky-high price-to-book ratio suggests the stock is richly valued, a discounted cash flow model implies massive upside potential. We examine the data behind the biotech's recent price swings and what investors are really betting on.
Gilead Sciences reports compelling Phase 3 data for its Trodelvy immunotherapy combined with Merck's Keytruda in frontline metastatic triple-negative breast cancer, marking a significant stride in its strategic pivot to expand beyond virology. The company also bolsters its pipeline through a new partnership with Repare Therapeutics.
As Bitcoin retreated from recent highs, MicroStrategy's massive holdings briefly slipped into unrealized loss territory, casting fresh doubt on the company's aggressive, debt-fueled crypto accumulation strategy and sending its shares tumbling.
JPMorgan Chase faces dual fronts of disruption as CEO Jamie Dimon's public critique of stablecoins at Davos highlights escalating tensions with the crypto sector, while a major lawsuit from former President Donald Trump alleges political bias, placing the banking giant's strategy and resilience under intense scrutiny.
As the Eurozone's patchy recovery creates divergent opportunities, we spotlight three small-cap stocks—from Dutch media to Swedish medtech and satcom—that combine financial resilience with high-growth potential for the discerning investor.
Former President Bill Clinton and former Secretary of State Hillary Clinton have agreed to appear before the House Oversight Committee, averting a contempt vote after weeks of tense negotiations and political pressure surrounding the Jeffrey Epstein investigation.
Amidst energy sector turbulence, midstream giants Enbridge, Enterprise Products, and Energy Transfer offer investors high yields backed by fee-based, infrastructure-heavy business models.
Shares of Knight-Swift Transportation Holdings jumped sharply Monday after the trucking giant appointed former executive Joe Vitiritto as president, signaling a strategic shift to navigate a softening freight market and recent earnings slump.
Shares of Norwegian Cruise Line Holdings surged over 7% Monday, fueled by unprecedented booking figures for its newly announced ship, the Oceania Sonata, signaling robust consumer appetite in the luxury cruise segment.
